117 related articles for article (PubMed ID: 11364606)
1. Combination therapies improve outlook for children with HIV disease.
NIAID AIDS Agenda; 1997 Aug; ():10. PubMed ID: 11364606
[TBL] [Abstract][Full Text] [Related]
2. Major pediatric study stopped early: combination treatment better.
James JS
AIDS Treat News; 1997 Jul; (No 274):5-6. PubMed ID: 11364462
[TBL] [Abstract][Full Text] [Related]
3. Combo therapy for children and adolescents.
Treat Rev; 1997 Aug; (No 25):7. PubMed ID: 11364620
[TBL] [Abstract][Full Text] [Related]
4. A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team.
McKinney RE; Johnson GM; Stanley K; Yong FH; Keller A; O'Donnell KJ; Brouwers P; Mitchell WG; Yogev R; Wara DW; Wiznia A; Mofenson L; McNamara J; Spector SA
J Pediatr; 1998 Oct; 133(4):500-8. PubMed ID: 9787687
[TBL] [Abstract][Full Text] [Related]
5. ACTG 300 leaves many questions unanswered.
Gilden D
GMHC Treat Issues; 1997; 11(7-8):35-6. PubMed ID: 11364654
[TBL] [Abstract][Full Text] [Related]
6. Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection: final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903.
Berenguer J; González J; Ribera E; Domingo P; Santos J; Miralles P; Angels Ribas M; Asensi V; Gimeno JL; Pérez-Molina JA; Terrón JA; Santamaría JM; Pedrol E;
Clin Infect Dis; 2008 Oct; 47(8):1083-92. PubMed ID: 18781872
[TBL] [Abstract][Full Text] [Related]
7. ddI and d4T plus protease inhibitors.
GMHC Treat Issues; 1996 Nov; 10(11):8-9. PubMed ID: 11364012
[TBL] [Abstract][Full Text] [Related]
8. Dethroning AZT.
Gilden D; Falkenberg J; Torres G
GMHC Treat Issues; 1997 Feb; 11(2):10-3. PubMed ID: 11364106
[TBL] [Abstract][Full Text] [Related]
9. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team.
Englund JA; Baker CJ; Raskino C; McKinney RE; Petrie B; Fowler MG; Pearson D; Gershon A; McSherry GD; Abrams EJ; Schliozberg J; Sullivan JL
N Engl J Med; 1997 Jun; 336(24):1704-12. PubMed ID: 9182213
[TBL] [Abstract][Full Text] [Related]
10. Focusing on the second phase of plasma HIV-1 RNA clearance.
Lafeuillade A; Poggi C; Sayada C; Pellegrino P; Profizi N
AIDS; 1997 Feb; 11(2):264-6. PubMed ID: 9030385
[No Abstract] [Full Text] [Related]
11. ACTG 152: new insights into pediatric antiretroviral therapy.
Bowersox J
NIAID AIDS Agenda; 1996 Mar; ():3. PubMed ID: 11363798
[TBL] [Abstract][Full Text] [Related]
12. AZT and children.
Treat Rev; 1995; (no 17):2. PubMed ID: 11362295
[TBL] [Abstract][Full Text] [Related]
13. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
[TBL] [Abstract][Full Text] [Related]
14. Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial.
Lancet; 1997 May; 349(9063):1413-21. PubMed ID: 9164314
[TBL] [Abstract][Full Text] [Related]
15. Zidovudine therapy and HIV type 1 mutations in children with symptomatic HIV type 1 infection: effect of switching to didanosine or zidovudine plus didanosine therapy. Italian Multicenter Study Group on HIV Mutations in Children.
Principi N; Marchisio P; Esposito S; Rossi P; Gattinara GC; Galli L; Gabiano C; Zuccotti GV; Orlandi P
AIDS Res Hum Retroviruses; 1998 Dec; 14(18):1653-9. PubMed ID: 9870319
[TBL] [Abstract][Full Text] [Related]
16. A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial. Paediatric European Network for Treatment of AIDS.
AIDS; 1998 Oct; 12(14):F151-60. PubMed ID: 9792371
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral combination treatment prolongs life in people with HIV/AIDS.
Cooper EC
AMFAR Rep; 1996 Jan; ():1-5. PubMed ID: 11363617
[TBL] [Abstract][Full Text] [Related]
18. Pediatric treatment update.
Grubman S
GMHC Treat Issues; 1996 Mar; 10(3):7-9. PubMed ID: 11363392
[TBL] [Abstract][Full Text] [Related]
19. AZT: pediatric study changed after worse monotherapy survival.
AIDS Treat News; 1995 Feb; (no 217):8. PubMed ID: 11362307
[TBL] [Abstract][Full Text] [Related]
20. Nucleoside combinations for antiretroviral therapy: efficacy of stavudine in combination with either didanosine or lamivudine.
Fisher M
AIDS; 1998; 12 Suppl 3():S9-16. PubMed ID: 15168718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
